drugset / Trial / NCT06034197

Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy

NCT06034197 ↗

Phase 0 Terminated 9 enrolled Stephan Rogalla
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine the safety and feasibility of VGT-309 for the visualization of colorectal tumors in real-time using near-infrared (NIR) fluorescence endoscopy. In addition, signatures of 50+ biomarkers will be evaluated in biopsies using CODEX multi-plexing.

Timeline

Start
2024-02-07
Primary completion
2025-04-04
Completion
2025-04-04

Outcome

Outcome not reported

Stopped: “The drug supply expired and the sponsor is unable to provide an updated supply.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Abenacianine Diagnostic / imaging agent 0.32 mg/kg Intravenous

Indications